Calander Icon19 May 2020
Calander IconStart time: 19 May 2020 13.30 UK time

Event description

Convenor:
Jayne Shufflebotham, IQVIA
Performance tracking throughout the lifecycle of a drug

We have shown that the first 6 months after the launch of a product are crucial to future success and often determine the sales trajectory of the product1. Continuous performance tracking that allows for rapid course correction is key and still not well established with many companies.
The webinar will focus on general best-practices and outline how companies will be able to improve their tracking in a tangible and impactful way.
https://www.iqvia.com/library/white-papers/launch-excellence-v

Audience:
This webinar will be of interest to any level of the organisation, whether they are going to be involved in post launch performance tracking in the near future or wanting to understand the principles for future reference.

Speakers

 
Daniel Cadoni
IQVIA
Associate Consultant

 

Andrew Cleveland
IQVIA
Principal

Areas of expertise
Product forecasting
Due diligence
Go to market strategies (e.g. market and product assessment)
Launch planning and tracking

Profile overview
Joined IQVIA in May 2018
Prior to IQVIA, Daniel worked as a Management Consultant advising clients on performance improvement and performance management (e.g. budgeting, planning and forecasting)

Education
MSc in Management Engineering (Politecnico di Milano)
BSc in Business Information Systems (Dual Study Program with DHBW Mannheim and Ernst & Young)

Areas of expertise
Brand and Commercial Strategy
Sales Force Effectiveness and Comm Org Design
Launch Excellence
LoE Planning

Profile overview
Andrew (Andy) is a Principal in the Munich office, joining in November 2017
Prior experience includes eight years in aggregate with ZS Associates in the US & Europe and two years with Sandoz Pharmaceuticals near Munich

Education
BS, Industrial Engineering & Economics, Northwestern University

Agenda